ArticleJournal of gastrointestinal oncology2023

Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study.

Ya-Nan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.